Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the launch of its new Case Management Service, which has been specifically designed to address the unique challenges associated with the safe and timely delivery of advanced therapies to patients by providing professional supply chain oversight from program start to finish.
The JP Morgan Healthcare conference (JPM23) is running January 9-13, 2023, in San Francisco. It’s one of the biggest biotech conferences, possibly the biggest, with companies from all over the world coming (or attending virtually) to network with possible investors, present their companies’ progress and breakthrough, announce their annual financial and milestone guidance, and negotiate deals.
We at BioBuzz have always strived to center ourselves around the individuals who have worked to push the biohealth sphere to new heights. Our “5 Questions With…” series embodies this effort as we have highlighted professionals at all levels, from early career to the C-suite, from scientists to business developers to managers and directors. Regardless of position or title, the many individuals highlighted in 2022 are all changemakers in their own right and we greatly appreciate their work and contribution to this series.
Known as 4MLK, this project has been in the works for more than seven years, so it was with great celebration and fan fair that the University of Maryland, Baltimore (UMB) and Wexford Science & Technology, LLC unveiled the newest development project in the University of Maryland BioPark.
Catalent Biologics (Catalent), a global contract development and manufacturing organization (CDMO), is a leader in providing comprehensive solutions for life sciences companies of all sizes. Catalent’s 19,000+ employees and approximately 2,500 scientists partner with pharma, biotech, and consumer health companies to optimize product development, launch, and full life-cycle supply for patients around the world.
Here’s our Summer 2022 Roundup of top Maryland life sciences companies with more than 10 active job listings across a wide range of fields and experience levels.
Catalent is hiring across our Gene Therapy sites in Maryland! At Harman’s, we have a state-of-the-art cGMP, clinical through commercial gene therapy manufacturing facility. We are located just 5 miles [….]
Catalent is hiring across our Gene Therapy sites in Maryland! At Harman’s, we have a state-of-the-art cGMP, clinical through commercial gene therapy manufacturing facility. We are located just 5 miles [….]
The Baltimore biotech ecosystem is thriving. And new, big and bold life sciences development projects are in the works, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.
Geeta Peverada is a highly motivated, data-driven, and goal-oriented program management professional with over 12 years of experience in cancer research and gene therapy. She is bridging the gap between science and business through her expertise in client management and scientific knowledge. Her analytical, leadership, and management expertise has led to strengthened client partnerships at her current organization, Catalent Pharma Solutions.